Decentralized Finance Market Estimated to Experience a Hike in Growth by 2030: Grand View Research Inc.

 

Decentralized Finance (DeFi) Market Growth & Trends

The global decentralized finance market size is expected to reach USD 231.19 billion by 2030, expanding at a CAGR of 42.5% from 2022 to 2030, according to a new study conducted by Grand View Research, Inc. The industry is growing in terms of revenue due to rapid technological advancement and innovation in the crypto industry. Another element fueling the industry expansion is the degree of transparency and real-time settlement of financial transactions on DeFi (Decentralized Finance) networks. The rising popularity of DeFi services is anticipated to open new opportunities for industry growth. In addition, the increasing adoption and acceptance of crypto are driving growth.

For instance, in July 2022, Visa surveyed 2,250 small business owners across the globe. According to the survey, 25% of respondents said that they would be accepting crypto assets as payment options. The growing acceptance of crypto assets bodes well for industry growth. Visa anticipates that the DeFi movement is expected to lead to new business prospects for established banks and other financial services providers in the near future. Financial institutions will eventually be able to integrate end-to-end solutions as use cases continue to grow and solidify. For instance, financial firms might be able to provide institutional clients with asset securitization and financing under DeFi protocols.

They might also begin offering services designed specifically for Web 3.0 enterprises and business owners, such as risk management and compliance as a service or insurance underwriting for DeFi protocols. The DeFi sites emerged during the COVID-19 pandemic as investors looked for yield in response to historically low-interest rates. Most DeFi services offer similar services as conventional financial services but with less regulation, which was the prime reason investors shifted their interest toward DeFi during the COVID-19 pandemic. DeFi platforms are decentralized with no single entity exerting control, which is anticipated to open new growth opportunities for the industry.

Request a free sample copy or view the report summary: Decentralized Finance (DeFi) Market Report

Decentralized Finance Market Report Highlights

• The smart contracts segment is expected to witness significant growth over the forecast period. Decentralized contracts have various advantages, such as transparency

• The enforcement of smart contracts is intrinsically built into blockchain technology since every action is tracked and made visible to the public

• The payments segment is expected to witness the fastest CAGR over the forecast period. The growth can be ascribed to the disintermediation feature of DeFi, which can reduce transaction cost

• Asia Pacific is anticipated to witness the fastest CAGR over the forecast period. In 2022, YouGov and Visa surveyed 16,295 adults in 14 markets across the Asia Pacific

• It was discovered that 21% of Asia Pacific consumers had previously used DeFi services, which is anticipated to increase by 17% this year, and that 38% of consumers were interested in trying DeFi services in the upcoming six months

Access Press Release@ https://www.grandviewresearch.com/press-release/global-decentralized-finance-market

Decentralized Finance Market Segmentation

Grand View Research has segmented the global decentralized finance market based on component, application, and region:

DeFi Component Outlook (Revenue, USD Million, 2020 - 2030)

• Blockchain Technology

• Decentralized Applications (dApps)

• Smart Contracts

DeFi Application Outlook (Revenue, USD Million, 2020 - 2030)

• Assets Tokenization

• Compliance & Identity

• Marketplaces & Liquidity

• Payments

• Data & Analytics

• Decentralized Exchanges

• Prediction Industry

• Stablecoins

• Others

DeFi Regional Outlook (Revenue, USD Million, 2020 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Spain

• Asia Pacific

  • China

  • India

  • Japan

  • South Korea

• Latin America

  • Brazil

  • Mexico

• Middle East & Africa

List of Key Players in Decentralized Finance Market

• Compound Labs, Inc.

• MakerDAO

• Aave

• Uniswap

• SushiSwap

• Curve Finance

• Synthetix

• Balancer

• Bancor Network

• Badger DAO

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Otoscope Market to Record an Exponential CAGR by 2030: Grand View Research Inc.

 

Otoscope Market Growth & Trends 

The global otoscope market size is expected to reach USD 240.90 million by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.1% from 2022 to 2030. The rising prevalence of ENT-related disorders and increasing penetration of minimally invasive ENT procedures are among the key trends stimulating industry growth. According to the WHO, 5% of the global population suffers from hearing loss, which is nearly 432 million adults and 34 million children. Due to the growing awareness regarding the diagnosis of chronic otitis media, the demand for otoscopy is increasing.

A moderate impact has been observed during the COVID-19 outbreak on industry growth. In the worst-hit months of 2020, mass closure of ENT clinics and termination of elective surgical procedures in hospitals drove down sales of otoscopes. However, resumption of surgical procedures and gradual increase to reach the pre-pandemic surgical volume are expected to increase product demand and reduce revenue losses medical care providers and manufacturers suffer.

Moreover, introducing new products and incorporating new technologies by the industry players are expected to propel the market growth during the forecast period. For instance, in April 2021, Hill-Rom launched the new Welch Allyn PanOptic Plus Ophthalmoscope and MacroView Plus Otoscope to provide caregivers with better, brighter views in earlier diagnosis and treatment. 

Request a free sample copy or view report summary: Otoscope Market Report

Otoscope Market Report Highlights

• Based on type, the pocket otoscope segment accounted for a dominant share of above 65.0% in 2021 as it is comparatively less bulky, lighter in weight, and widely used by ENT practitioners

• Based on portability, the portable segment held the largest share of over 70.0% in 2021. This type of otoscope allows greater mobility and can be used anywhere in the clinic and even on home visits

• The hospital end-user segment dominated the market with a share of over 50.0% in 2021

• North America captured a leading revenue share of over 30.0% in 2021 owing to the increasing burden of diseases related to ENT and the introduction of technologically advanced products in the region 

Access Press Release@ https://www.grandviewresearch.com/press-release/global-otoscopes-market

Otoscope Market Segmentation

Grand View Research has segmented the global otoscope market on the basis of type, modality, portability, end-user, and region:

Otoscope Type Outlook (Revenue, USD Million, 2018 - 2030)

• Pocket Otoscope

• Full-sized Otoscope

• Video Otoscope

Otoscope Modality Outlook (Revenue, USD Million, 2018 - 2030)

• Wired Digital

• Wireless

Otoscope Portability Outlook (Revenue, USD Million, 2018 - 2030)

• Wall-mounted

• Portable

Otoscope End-user Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• ENT Clinics

• Others

Otoscope Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

  • Colombia

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE 

List of Key Players of the Otoscope Market

• Welch Allyn, Inc.

• 3M

• American Diagnostic Corporation

• Orlvision GmbH

• SyncVision Technology Corporation

• Rudolf Riester GmbH

• Heine Optotechnik

• Mindmark Corporation

• Olympus Corporation

• Inventis SRL

• Prestige Medical

• GF Health Products, Inc.

• CellScope, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Data Fabric Market Poised to Garner Maximum Revenues During 2022– 2030: Grand View Research Inc.

 

Data Fabric Market Growth & Trends

The global data fabric market size is expected to reach USD 8.49 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 21.2% from 2022 to 2030. In an extensive data system, data fabric is one of the most significant architectures, providing seamless, real-time integration and access across diversified data silos. There is a considerable growth opportunity in the market that will revolutionize how data is collected, analyzed, and managed.

Data analytics and big data play a more significant role in driving the growth of the global market since they integrate disparate sources of data and provide analytics on them. As data accessibility and business agility become more critical, there is an increase in the adoption of data fabric platforms, which give tools access to data through a wide range of interfaces. However, a lack of data fabric awareness and the absence of a skilled workforce are some factors that hamper the market's growth to a certain extent. In addition, digitalization is a lucrative opportunity for the market growth of data fabrics in emerging economies worldwide.

Traditional programs could be replaced by experiences powered by metadata owing to an accurate data fabric. Although the end user may not recognize the distinction between such experiences and APIs, developing the architecture is easy. The data fabric's network effects, such as data catalog, data integration, and data management, are its most promising feature. A genuine data fabric improves efficiency as it is used more frequently.

The COVID-19 epidemic has only accelerated the market for data fabric's strategic orientation. Data and analytics executives understand that they require automation help rather than continuing to invest in human data integration. Teams that integrate data are constantly changing. The volume of data and, thus, the number of requirements for data integration are increasing exponentially even as team sizes are decreasing. This disparity between supply and demand shows that automation and augmentation must be urgently prioritized. The data fabric architectural design, a crucial use case for this year, must be given increased attention to supporting augmented data integration.

Request a free sample copy or view report summary: Data Fabric Market Report

Data Fabric Market Report Highlights

• Europe is expected to witness significant growth over the forecast period. The significant factors contributing to the market's development include increasing volume and variety of business data

• Government regulations and data security abiding laws are expected to act as a catalyst in driving the fraud detection and security management segment

• Data fabric utilizes ML capabilities of data integration, knowledge graphs, and active metadata enabling faster access to trusted data across distributed landscapes

• Asia Pacific is anticipated to witness the highest CAGR during the forecast period. Growing AI and ML adoption across the industries in the region is expected to support the growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-data-fabric-market

Data Fabric Market Segmentation

Grand View Research has segmented the global data fabric market based on component, deployment, type, enterprise size, business applications, industry, and region:

Data Fabric Component Outlook (Revenue, USD Million, 2017 - 2030)

• Solution

• Services

Data Fabric Deployment Outlook (Revenue, USD Million, 2017 - 2030)

• On-premise

• Cloud

Data Fabric Type Outlook (Revenue, USD Million, 2017 - 2030)

• Disk-based Data Fabric

• In-memory Data Fabric

Data Fabric Enterprise Size Outlook (Revenue, USD Million, 2017 - 2030)

• Small and Medium Enterprise

• Large Enterprise

Data Fabric Business Applications Outlook (Revenue, USD Million, 2017 - 2030)

• Fraud Detection and Security Management

• Governance, Risk and Compliance Management

• Customer Experience Management

• Sales and Marketing Management

• Business Process Management

• Other Applications

Data Fabric Industry Outlook (Revenue, USD Million, 2017 - 2030)

• BFSI

• Telecommunications & IT

• Retail & Ecommerce

• Healthcare

• Manufacturing

• Transportation & Logistics

• Media & Entertainment

• Others

Data Fabric Region Outlook (Revenue, USD Million, 2017 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • U.K.

  • Germany

  • France

• Asia Pacific

  • China

  • Japan

  • India

• Central and South America

  • Brazil

• Middle East & Africa

List of Key Players in the Data Fabric market

• Atlan Pte. Ltd

• IBM

• Oracle

• Talend

• SAP

• Informatica Inc.

• Cloudera Inc.

• TIBCO Software Inc.

• Amazon Web Services, Inc.

• data.world, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Infectious Respiratory Disease Diagnostics Market Growth in the Coming Years

 

Infectious Respiratory Disease Diagnostics Market Growth & Trends

The global infectious respiratory disease diagnostics market size is expected to reach USD 43.6 billion by 2030, registering a CAGR of -1.8% over the forecast period, according to a new report by Grand View Research, Inc. The decline in market size is majorly attributed to the decline in COVID-19 testing. However, the market without the impact of COVID-19 is expected to grow over the forecast years. The growth can be attributed to an increase in the prevalence of infectious respiratory diseases and initiatives taken by governments & nonprofit organizations to introduce novel & innovative products to address the increasing demand. For instance, the global investment in tuberculosis R&D reached USD 915 million, and around USD 401 million was spent by the U.S. government on TB research in 2020.

During the forecast period, the global industry is expected to be driven by the rising incidence of infectious respiratory disorders, such as tuberculosis, RSV, and influenza. According to the UN, pneumonia affects around 4.2 million people every year. Key players are developing innovative techniques to improve production for meeting the growing demand in diagnostics and consumables for the diagnosis of infectious diseases. For instance, OPT Industries Inc. has introduced InstaSwab by utilizing the 3D printing system to address supply shortages of sample collection kits due to the COVID-19 pandemic. These swabs are made of woven lattices to absorb and release more fluid than conventional swabs. Companies are advancing their diagnosis products by using new techniques to gain target-specific and accurate results.

Canon Inc. announced the development of a built-in AEC assistance for digital X-rays in March 2021. The X-ray image sensor enables users to perform picture production and real-time detection of images corresponding to emitted X-rays. Furthermore, in May 2021, the University of California developed an ultrasensitive molecular test to identify the presence of SARS-CoV-2 and influenza A antigens using chip technology. In addition, companies are also launching multiplex tests for the simultaneous diagnosis of RSV, influenza, and COVID-19 respiratory diseases. RT-PCR tests are considered the gold standard for the diagnosis of COVID-19 in patients. However, high prices associated with molecular tests are one of the major factors impeding this market.

The lack of comparable products is another reason for hiked prices. This problem is further compounded by the significant variations in prices for different applications of each molecular diagnostic product. Companies are adopting strategies, such as new product launches and partnerships, to increase the penetration of infectious respiratory disease diagnostics products. For instance, in August 2021, Thermo Fisher Scientific Inc. received EUA for the introduction of two COVID-19 diagnostic products, TaqPath COVID-19 RNase P Combo Kit and TaqPath COVID-19 Fast PCR Combo Kit, in the U.S. market.

Request a free sample copy or view report summary: Infectious Respiratory Disease Diagnostics Market Report

Infectious Respiratory Disease Diagnostics Market Report Highlights

• In 2021, the consumables segment accounted for the largest revenue share and is anticipated to maintain its dominance over the forecast period owing to high testing rates for the diagnosis of COVID-19 and the commercialization of multiple assays in recent years

• Molecular diagnostics accounted for the highest revenue share in 2021, owing to the increasing use of PCR technology for COVID-19 diagnosis

• The nasopharyngeal swabs sample type segment accounted for the highest revenue share in 2021 owing to high usage in COVID-19 diagnosis

• The COVID-19 application segment led the industry in 2021 due to factors, such as high incidence rate, increasing product approvals, and high R&D initiatives for launching innovative products

• Tuberculosis is expected to exhibit the fastest CAGR over the forecast period owing to increasing government focus and R&D funding for the development of diagnostics

• Asia Pacific is expected to experience the fastest growth over the forecast period owing to an increase in penetration of IVD products, rise in disposable income, and high prevalence of tuberculosis in underdeveloped countries

Access Press Release@ https://www.grandviewresearch.com/press-release/global-infectious-respiratory-disease-diagnostics-market

Infectious Respiratory Disease Diagnostics Market Segmentation

Grand View Research has segmented the global infectious respiratory disease diagnostics market on the basis of product type, sample type, application, technology, end-use, and region:

Infectious Respiratory Disease Diagnostics Product Type Outlook (Volume ‘000; Revenue, USD Million, 2018 - 2030)

• Instruments

  • Imaging Tests

  • Respiratory Measurement Devices

  • Other Instruments

• Consumables

• Services

Infectious Respiratory Disease Diagnostics Sample Type Outlook (Volume ‘000; Revenue, USD Million, 2018 - 2030)

• Saliva

• Nasopharyngeal Swabs (NPS)

• Anterior Nasal Region

• Blood

• Others

Infectious Respiratory Disease Diagnostics Application Outlook (Volume ‘000; Revenue, USD Million, 2018 - 2030)

• COVID-19

• Influenza

• Respiratory Syncytial Virus (RSV)

• Tuberculosis

• Streptococcus Testing

• Other Respiratory Disease Testing

Infectious Respiratory Disease Diagnostics Technology Outlook (Volume ‘000; Revenue, USD Million, 2018 - 2030)

• Immunoassay

• Molecular Diagnostics

• Microbiology

• Other Technologies

Infectious Respiratory Disease Diagnostics End-use Outlook (Volume ‘000; Revenue, USD Million, 2018 - 2030)

• Hospitals

• Diagnostic Laboratories

• Physician Offices

• Other End-users

Infectious Respiratory Disease Diagnostics Regional Outlook (Volume ‘000; Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • Spain

  • France

  • Italy

  • Russia

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

  • Singapore

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • Saudi Arabia

  • UAE

  • South Africa

List of Key Players of Infectious Respiratory Disease Diagnostics Market

• Abbott

• Thermo Fisher Scientific, Inc.

• Koninklijke Philips N.V.

• F. Hoffmann-La Roche Ltd.

• BD

• bioMérieux SA

• Bio-Rad Laboratories, Inc.

• Quidel Corporation

• Siemens Healthcare GmbH

• Danaher

• Qiagen

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Plasmid DNA Manufacturing Market To Benefit from Increased Global Uptake of 2022 to 2030

 

Plasmid DNA Manufacturing Market Growth & Trends

The global plasmid DNA manufacturing market size is expected to reach USD 1.51 billion by 2030, registering a CAGR of 13.71% over the forecast period, according to a new report by Grand View Research, Inc. The rising prevalence of chronic diseases, combined with the wide application scope of plasmid DNA in the healthcare industry is expected to drive the industry growth. Plasmid DNA can be used directly for therapeutic applications, such as the production of vaccine antigens or gene therapy. Moreover, it can be utilized for various research purposes, such as gene cloning, gene mapping, etc. The rising number of patients choosing gene therapy is expected to drive industry growth in the coming years.

According to clinicaltrials.gov, the number of cell & gene therapies across global pipeline programs (Phase I to Phase III trials) increased from 289 in 2018 to 327 in 2022. Furthermore, the U.S. FDA provides constant support for innovations in the advanced therapy arena via several policies concerning product manufacturing. With increased cell and gene therapy products, the industry will see an increased need for manufacturing plasmid DNA on a larger scale. The COVID-19 pandemic is anticipated to positively impact industry growth. For instance, in September 2021, India approved the first COVID-19 DNA vaccine. It is the world’s first COVID-19 DNA vaccine manufactured in partnership with DBT-BIRAC as part of Mission COVID Suraksha.

Circular DNA is used in India’s ZyCoV-D vaccination to protect against COVID-19 infection. Furthermore, key entities in the global industry are undertaking various strategic initiatives to strengthen their market presence, which is also expected to propel growth. For instance, in June 2022, BioCina announced the expansion of the production of plasmid DNA in a new dedicated GMP suite to its offering of CDMO services. The suite has a single-use fermentation capacity of up to 300 L and appropriately scaled downstream processing machinery.

Request a free sample copy or view report summary: Plasmid DNA Manufacturing Market

Plasmid DNA Manufacturing Market Report Highlights

• The GMP grade type segment held the largest revenue share in 2021. GMP-grade plasmid DNAs are broadly utilized in pre-clinical trials in gene therapy or vaccination including biodistribution and toxicology studies

• The clinical therapeutics segment dominated the global industry in 2021 owing to the increased importance of plasmid DNA for clinical research applications in genetic vaccination

• The infectious diseases segment held a significant revenue in 2021. DNA plasmid is effectively utilized in the treatment of several infectious disorders as it delivers a strong immunity via vaccine antigen and prevents pathogen infections

• The cell & gene therapy application segment led the industry in 2021 owing to the high demand for gene therapy for the treatment of several inherited diseases and genetic disorders

• North America was the dominant regional market in 2021 due to improved healthcare infrastructure, high disposable income, presence of a substantial number of centers and institutes that are engaged in R&D of advanced therapies, and increased adoption of advanced therapies in the region

• Asia Pacific is anticipated to register the fastest CAGR during the forecast years on account of the increasing R&D activities in this field and the presence of key players

Access Press Release@ https://www.grandviewresearch.com/press-release/global-plasmid-dna-manufacturing-market

Plasmid DNA Manufacturing Market Segmentation

Grand View Research has segmented the global plasmid DNA manufacturing market based on grade, development phase, application, disease, and region:

Plasmid DNA Manufacturing Grade Scope Outlook (Revenue, USD Million, 2018 - 2030)

• R&D Grade

• GMP Grade

Plasmid DNA Manufacturing Development Phase Scope Outlook (Revenue, USD Million, 2018 - 2030)

• Pre-clinical Therapeutics

• Clinical Therapeutics

• Marketed Therapeutics

Plasmid DNA Manufacturing Application Scope Outlook (Revenue, USD Million, 2018 - 2030)

• DNA Vaccines

• Cell & Gene Therapy

• Immunotherapy

• Others

Plasmid DNA Manufacturing Disease Scope Outlook (Revenue, USD Million, 2018 - 2030)

• Infectious Disease

• Cancer

• Genetic Disorder

Plasmid DNA Manufacturing Regional Scope Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

List of Key Players of Plasmid DNA Manufacturing Market

• Charles River Laboratories

• VGXI, Inc.

• Aldevron

• Kaneka Corp.

• Nature Technology

• Cell and Gene Therapy Catapult

• Eurofins Genomics

• Lonza

• Luminous BioSciences, LLC

• Akron Biotech

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Impact of Existing and Emerging Automatic Identification And Data Capture Market Trends And Forecast 2022-2030: Grand View Research Inc.

 Automatic Identification And Data Capture Market Growth & Trends

The global automatic identification and data capture market size is expected to reach USD 131.48 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.7% from 2022 to 2030. With an increase in the use of smartphones for image recognition and QR code scanning along with an increase in the development of e-commerce platforms internationally, the market is anticipated to experience a noticeable growth during the forecast period.

Furthermore, increased automatic identification and data capture (AIDC) solution acceptance due to their capacity to reduce discrepancies is likely to drive the growth of the AIDC industry during the forecast period. For instance, in April 2022, Arcion Labs, Inc., a truly real-time database replication platform, announced the release of Arcion Cloud, a fully managed change data capture data replication as a service that empowers businesses to leverage more significant, big data pipelines in minutes.

The most prevalent devices used to identify and capture the data are RFID scanners and RFID tags, barcode scanners, fixed-position, and handheld laser scanners and imagers, wearables devices, voice recognition solutions, and rugged tablets. Automatic identification and data capture systems, such as wearables, barcoding solutions, and RFID scanners, are critical in e-commerce and warehouse management.

AIDC technology not only assists the e-commerce business in automatically identifying objects, collecting data about them with high accuracy and precision, and electronically entering this data into the computer system. By keeping track of inventories, accounting, human resources, and overall procedures, technology also helps increase productivity and operational efficiency.

For instance, in August 2022, BE Switchcraft Pty Ltd, a manufacturer of electronic and electrical components, endorsed Zebra Technologies Corp.'s radio frequency identification (RFID) solution to obtain real-time visibility of its production process and financial data. The solution allows the BE Switchcraft team to see each stage of the switchboard production process in real time. The collected data is integrated with the company's enterprise resource planning system to offer essential updates on each project's status and financial data for projects in production.

Rising government laws requiring AIDC technology are driving demand for these systems. Over the last decade, governments worldwide have passed legislation to encourage the use of AIDC technologies in various industries to address the issue of rising data entry errors and associated operating costs. These laws and regulations are intended to assist enterprises in ensuring improved information visibility, improving operational efficiency, lowering operating costs through accurate data capture and fewer data input errors, and increasing customer satisfaction.

For instance, in August 2022, Delhi International Airport Limited (DIAL) announced the launch of a beta version of DigiYatra, an app based on facial recognition technology to recognize travelers. The initiative intends to provide a paperless & seamless travel experience, following the Government of India's regulations for providing contactless, effortless processing of passengers at airports.

Request a free sample copy or view report summary: Automatic Identification And Data Capture Market Report

Automatic Identification And Data Capture Market Report Highlights

• The widespread acceptance of sophisticated technology and the technological development of numerous industries are driving the growth of the North American region

• AIDC systems are routinely used to manage assets, inventory, delivery, document scanning, and security in various industries, including transport and logistics, chemical, pharmaceutical, food and beverage, automotive, consumer products, retail and warehousing, and distribution

• Radio Frequency Identification (RFID) tags, barcodes, biometrics, labels, smart cards, and speech and voice recognition have gained acceptance across various industries due to their increased accuracy, precision, and smooth functioning

• Banks and financial institutions' increasing implementation of AIDC solutions to ensure customer security, safety, and data privacy is projected to fuel market expansion

Access Press Release@ https://www.grandviewresearch.com/press-release/global-automatic-identification-data-capture-market

Automatic Identification And Data Capture Market Segmentation

Grand View Research has segmented the global automatic identification and data capture market based on component, end-user, and region:

Automatic Identification & Data Capture Component Outlook (Revenue, USD Billion, 2017 - 2030)

• Hardware

  • RFID Reader

  • Barcode Scanner

  • Smart Cards

  • Optical Character Recognition Devices

  • Biometric Systems

  • Others

• Software

• Services

  • Integration & Installation Services

  • Support & Maintenance Services

Automatic Identification & Data Capture End-user Outlook (Revenue, USD Billion, 2017 - 2030)

• Manufacturing

• Retail

• Transportation & Logistics

• Hospitality

• BFSI

• Healthcare

• Government

• Energy & power

• Others

Automatic Identification & Data Capture Regional Outlook (Revenue, USD Billion, 2017 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • U.K.

  • Germany

  • France

• Asia Pacific

  • China

  • India

  • Japan

• Central & South America

  • Brazil

• Middle East & Africa

List of Key Players in Automatic Identification And Data Capture Market

• Bluebird Inc

• B.O.S. BETTER ONLINE SOLUTIONS LTD.

• Cognex Corporation

• Datalogic S.p.A.

• Honeywell International Inc

• NEC Corporation

• Panasonic Holdings Corporation

• Thales

• TOSHIBA CORPORATION

• Zebra Technologies Corp.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Synthetic Small Molecule API Market to Expand at a CAGR of 5.73% Through 2030: Grand View Research Inc.

 

Synthetic Small Molecule API Market Growth & Trends

The global synthetic small molecule API market size is expected to reach USD 217.17 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 5.73% from 2022 to 2030. This can be attributed to the increasing demand for pharmaceuticals and new small molecule-based drugs globally. Moreover, small molecules API offers versatility between dosage forms and has an easier means of purification, which makes it more acceptable and increases the demand.

There is an increasing dominance of synthetic drugs in the pharmaceutical industry, which is expected to propel the requirement of raw materials such as small molecule APIs for production. Moreover, technological advancements related to the enhancement of existing products are expected to provide new opportunities for small molecule therapeutics. For instance, in March 2022, Evonik launched the new EUDRATECSoluFlow technology that enhances the solubility of oral small molecules.

The market is driven by positive government support for the production of APIs in various regions, particularly in Asia, where the majority of API manufacturers are dependent on the supply of API for the production of synthetic small molecule APIs. There has been an increasing focus on outsourcing activities for API production. For instance, in April 2020, for managing COVID-19, Wavelength Pharmaceuticals expanded the supply of key drug ingredients for certain pharmaceutical products needed to manage respiratory critical care patients and launched API CDMO services. Emerging markets such as China, India, and Southeast Asia represent significant opportunities for growth.

The investment in new and complex technologies is relatively low for Asian manufacturers as they are more focused on less complex molecules that can be produced in bulk. Thus, the investment in high-yielding, low-cost technologies is an alternative for manufacturers in other developed regions such as Europe and North America to avoid competitive pressure.

Key players operating in the market are focusing on collaboration for the production of potent API products. For instance, in August 2021, Almac Sciences signed an agreement with Pila Pharma for the production of the API XEN-D0501, a highly potent and selective small molecule TRPV1 antagonist. Moreover, CDMOs are constantly evolving by expanding their capacities to meet the heightened demand for synthetic drugs. For instance, in April 2022, AGC Inc. announced the expansion of its Spanish facility by 7500 m² for synthetic pharmaceutical production, which is expected to enhance the demand for synthetic small molecule active pharmaceutical ingredients in the region.

Request a free sample copy or view report summary: Synthetic Small Molecule API Market Report

Synthetic Small Molecule API Market Report Highlights

• The growth of the overall market is attributed to the increasing production of pharmaceuticals with the increased demand for raw material

• The API market is witnessing a key shift with the rise in the preference for CDMOs for the production of synthetic small molecule active pharmaceutical ingredients in bulk

• By manufacturer, the outsourced segment is expected to witness lucrative growth over the forecast period owing to a dependency of small and mid-sized companies on outsourcing for commercial production

• The cardiology appolication segment dominated the market in 2021. This is attributed to the increasing prevalence of target diseases

• North America dominated the market in 2021 due to the presence of key players and rising support from the government for enhancing the API manufacturing capacity of the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-synthetic-small-molecule-api-market

Synthetic Small Molecule API Market Segmentation

Grand View Research has segmented the global synthetic small molecule API market on the basis of manufacturer, application, and region:

Synthetic Small Molecule API Manufacturer Outlook (Revenue, USD Billion, 2018 - 2030)

• In-house

• Outsourced

Synthetic Small Molecule API Application Outlook (Revenue, USD Billion, 2018 - 2030)

• Cardiology

• Oncology

• CNS and Neurology

• Orthopedic

• Endocrinology

• Pulmonology

• Gastroenterology

• Nephrology

• Ophthalmology

• Others

Synthetic Small Molecule API Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Spain

  • Italy

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

List of Key Players of Synthetic Small Molecule API Market

• Bristol-Myers Squibb Company

• Cipla, Inc.

• Boehringer Ingelheim International GmbH

• Merck & Co., Inc.

• AbbVie, Inc.

• Aurobindo Pharma

• Sun Pharmaceutical Industries Ltd.

• Teva Pharmaceutical Industries Ltd.

• Albemarle Corporation

• Viatris Inc.

• Dr. Reddy’s Laboratories Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Expansion of Pharmacovigilance Market During 2023– 2030 to Gain Robust Traction: Grand View Research Inc.

 

Pharmacovigilance Market Growth & Trends

The global pharmacovigilance market size is expected to reach USD 17.36 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 10.3% from 2023 to 2030. The increasing incidence of Adverse Drug Reactions (ADR) is a key growth factor. ADR imposes a substantial burden on healthcare systems and is one of the prominent causes of morbidity in developed countries. According to the National Center for Biotechnology Information (NCBI), approximately 5% of total hospitalizations in Europe each year are due to ADR. Pharmacovigilance services play an integral role in this clinical trial phase by assisting manufacturers in identifying adverse effects associated with the drug.

COVID-19 has undoubtedly thrown up numerous challenges as well as opportunities for pharmacovigilance service providers. Various companies are developing innovative platforms to gain a competitive edge. For instance, in December 2020, ArisGlobal and EVERSANA declared a strategic partnership to digitally transform end-to-end pharmacovigilance services globally.

The community involved in PV procedure has been quick to respond to the pandemic. Some companies are using big data analytics against COVID-19. Thus, this refers to a depth analysis of data from multiple sources. In April 2020, Saama Technologies offered its Life Science Analytics Cloud technology platform to support the consortium creation. The purpose is to fetch data from both current and future studies to slash the time required to discover a treatment by as much as 50%. Life Science Analytics Cloud is an artificial intelligence-powered platform. This represents the scope for future developments in this market.

According to the World Health Organization's (WHO) report on pharmaceutical consumption, chronic disease medications accounted for a larger proportion of the total volume of drug consumption in non-hospital setups. Hence, there has been a significant rise in the number of medicines made available to healthcare consumers. The rising demand for drugs has significantly heightened the need for the development of novel therapeutics via extensive clinical trials, which is expected to serve this market with lucrative opportunities.

Moreover, leading pharma companies in developed countries are focusing on outsourcing PV services to reduce costs and minimize operational expenses. This is anticipated to provide an opportunity to contact research organizations in developing regions to gain more revenue share. Manufacturers are now focusing on remodeling their product development processes in an attempt to cater to patient needs across the globe. These factors are anticipated to fuel the demand for pharmacovigilance services during the forecast period.

The companies operating in the market are undertaking strategic initiatives, such as collaborations with PV service providers to gain access to medical information and manage PV workflows. For instance, In October 2021, The Whiteboard, an academy for training specialists in the clinical trials and drug development field, proclaimed a partnership with OviyaMedSafe, a worldwide drug safety service and pharmacovigilance consulting corporation.

Similarly, in September 2019, Accenture collaborated with Bayer to implement the company's INTIENT Clinical platform to simplify and speed up its drug development processes, thereby widening its business. The company collaborated with BioCelebrate in the past to develop a platform for aggregating and analyzing clinical information for improving the efficiency of drug development, thus enhancing its R&D capabilities. Such initiatives help companies maintain their position and thereby support the market growth.

Request a free sample copy or view report summary: Pharmacovigilance Market Report

Pharmacovigilance Market Report Highlights

• By product life cycle, phase IV held a dominant share of over 75.8% in 2022 owing to the extensive post-marketing surveillance of pharmaceuticals and an increasing number of ADR incidences in the market

• By service provider, contract outsourcing held a significant share of over 60.0% in 2022 owing to the shift in the focus of pharmaceutical companies toward outsourcing services to reduce operational cost

• Based on type, spontaneous reporting held the largest revenue share in 2022 due to its wide application in pharmacovigilance and benefits such as easy simulation of data sets for better drug comparison

• The biotechnology companies end-use segment is anticipated to exhibit a lucrative CAGR over the forecast period owing to increasing R&D for the development of novel biologics

• Asia Pacific is anticipated to register a lucrative CAGR of 10.8% over the forecast period. This is attributed to the availability of low-cost labor and the rising number of outsourcing companies in this region

• Industry participants are focusing on increasing R&D activities to develop better pharmacovigilance services. Moreover, companies are adopting strategies including new product launches, collaborations, and mergers & acquisitions to gain a competitive advantage

Access Press Release@ https://www.grandviewresearch.com/press-release/global-pharmacovigilance-market

Pharmacovigilance Market Segmentation

Grand View Research has segmented the global pharmacovigilance market on the basis of product life cycle, service provider, type, process flow, therapeutic area, end-use, and region:

Pharmacovigilance Product Life Cycle Outlook (Revenue, USD Million, 2017 - 2030)

• Pre-clinical

• Phase I

• Phase II

• Phase III

• Phase IV

Pharmacovigilance Service Provider Outlook (Revenue, USD Million, 2017 - 2030)

• In-house

• Contract Outsourcing

Pharmacovigilance Type Outlook (Revenue, USD Million, 2017 - 2030)

• Spontaneous Reporting

• Intensified ADR Reporting

• Targeted Spontaneous Reporting

• Cohort Event Monitoring

• EHR Mining

Pharmacovigilance Process Flow Outlook (Revenue, USD Million, 2017 - 2030)

• Case Data Management

  • Case Logging

  • Case Data Analysis

  • Medical Reviewing & Reporting

• Signal Detection

  • Adverse Event Logging

  • Adverse Event Analysis

  • Adverse Event Review & Reporting

• Risk Management System

  • Risk Evaluation System

  • Risk Mitigation System

Pharmacovigilance Therapeutic Area Outlook (Revenue, USD Million, 2017 - 2030)

• Oncology

• Neurology

• Cardiology

• Respiratory Systems

• Others

Pharmacovigilance End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Pharmaceuticals

• Biotechnology Companies

• Medical Device Manufacturers

• Others

Pharmacovigilance Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Russia

• Asia Pacific

  • Japan

  • China

  • India

• Latin America

  • Brazil

  • Mexico

• MEA

  • South Africa

  • Kingdom of Saudi Arabia

List of Key Players of Pharmacovigilance Market

• Accenture

• Clinquest Group B.V. (Linical Americas)

• IQVIA

• Cognizant

• Laboratory Corporation of America Holdings

• IBM Corporation

• ArisGlobal

• ICON Plc.

• Capgemini

• ITClinical

• TAKE Solutions

• PAREXEL International Corporation

• BioClinica, Inc.

• Wipro Limited

• UNITED BIOSOURCE CORPORATION

• FMD K&L

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Extended Detection And Response Market to Register Stable Expansion During 2022 – 2030: Grand View Research Inc.

 

Extended Detection And Response Market Growth & Trends

The global extended detection and response market size is expected to reach USD 3.41 billion by 2030, growing at a CAGR of 20.7% from 2022 to 2030, according to a study conducted by Grand View Research, Inc. The market benefits from the growing adoption of BYOD and enterprise mobility trends across organizations, the need to mitigate IT security risks, and the increasing number of enterprise-targeted cyber-attacks across the globe. Extended Detection and Response (XDR) solutions help security professionals to visualize cyber threat patterns holistically. Additionally, XDR tools help centralize and normalize data in a central repository to analyze data security incidents faster, giving organizations greater control over security to defend against vulnerabilities.

Cyber threat risks and the challenges faced in securing critical data are intensifying with the increasing adoption of technologies such as IoT and cloud. Detecting, responding, and mitigating such threats across several control points is complex as organizations deploy numerous solutions that collectively generate a large number of alerts. This has increased the demand for a comprehensive solution that extends the capabilities of endpoint detection to the detection of incidents across several security control points. Unlike EDR solutions that remove only endpoint threats, XDR solutions offer a 360-degree view of the security environment.

The COVID-19 pandemic has led to the heightened need for XDR tools as organizations were required to implement remote working models. The abrupt transition allowed several cyber threat actors to target vulnerable endpoints and a spike in phishing, ransomware, and spam was observed across organizations. Recently, a joint alert was issued by the U.K. and the U.S. Federal cyber agencies declaring that the COVID-19 crisis is being exploited by cyber-attackers to compromise the endpoints used for remote work by employees.

The National Cyber Security Centre (NCSC), Cybersecurity and Infrastructure Security Agency (CISA), and Department of Homeland Security (DHS) shared the observations concentrating on some of the latest incidents. The need to effectively detect and mitigate incidents across a dynamic security framework has led to the increased demand for unified detection and response solutions.

Request a free sample copy or view report summary: Extended Detection And Response Market Report

Extended Detection And Response Market Report Highlights

• In terms of component, the solutions segment dominated the market in 2021 and is expected to register significant growth over the forecast period. This can be attributed to the rising demand for comprehensive detection solutions across organizations of all sizes

• In terms of deployment type, the on-premises segment is expected to dominate the extended detection and response market over the forecast period. This can be attributed to the need for an optimum level of data security with security protocols and physical access controls across organizations

• The large enterprises segment dominated the extended detection and response industry owing to the increased spending on security infrastructures and cloud technologies

• North America accounted for the largest revenue share in 2021, attributed to the high investment of organizations in the region in security solutions

• The prominent market participants include McAfee, LLC; Trend Micro Incorporated; Microsoft; Palo Alto Networks, Inc.; Cybereason; Broadcom; Cynet; and SentinelOne

Access Press Release@ https://www.grandviewresearch.com/press-release/global-extended-detection-response-market

Extended Detection And Response Market Segmentation

Grand View Research has segmented the global extended detection and response (XDR) market based on component, deployment type, application, and region:

Extended Detection And Response Component Outlook (Revenue, USD Million, 2018 - 2030)

• Solution

• Services

Extended Detection And Response Deployment Type Outlook (Revenue, USD Million, 2018 - 2030)

• On-premises

• Cloud

Extended Detection And Response Application Outlook (Revenue, USD Million, 2018 - 2030)

• Large Enterprises

• SMEs

Extended Detection And Response (XDR) Regional Outlook (Revenue, USD Million; 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

• Asia Pacific

  • China

  • India

  • Japan

• Latin America

  • Brazil

  • Mexico

• Middle East & Africa

List of Key Players of Extended Detection And Response Market

• McAfee, LLC

• Trend Micro Incorporated

• Microsoft

• Palo Alto Networks.

• Cybereason

• Broadcom

• Cynet

• SentinelOne

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.